Clinical Efficacy and Mechanism of Yisui Granule in Treatment of Low and Medium Risk Myelodysplastic Syndrome Through Demethylation

NCT05687513 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

76

Enrollment

OTHER

Sponsor class

Conditions

MDS

Interventions

DRUG: Yisui granule
DRUG: Placebo

Sponsor

Dongzhimen Hospital, Beijing